finance.yahoo.com
Positivefinance.yahoo.com ·
lemaitre lmat q1 earnings report 014055564
WB_1331_HEALTH_TECHNOLOGIESWB_621_HEALTH_NUTRITION_AND_POPULATIONWB_1362_MEDICAL_EQUIPMENTTAX_FNCACT_ANALYST
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedLeMaitre Vascular (LMAT) is a medical device company. The article is a routine earnings preview with no concrete commercial mechanism beyond the company's own revenue growth and sector sentiment. No supply chain disruption, regulatory change, or margin squeeze is identified. The impact is company-specific and weak.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- LeMaitre Vascular to report Q1 earnings on Tuesday after market hours.
- Previous quarter revenues: $64.45 million, up 15.7% YoY, beating expectations.
- Analysts expect 11.4% revenue growth for upcoming quarter.
- Stock price stable at $108.97, average analyst target $111.22.
- Healthcare equipment sector positive sentiment; peers Intuitive Surgical and Baxter reported strong growth.